Literature DB >> 1980606

No evidence for loss of alleles at 11p in HBV negative hepatocellular carcinomas.

M Kiechle-Schwarz1, G Scherer, G Kovacs.   

Abstract

The aim of the present study was to determine whether loss of DNA sequences at the chromosome arm 11p, where presumed tumor suppressor genes are located, might occur in hepatocellular carcinomas (HCCs) of hepatitis B virus (HBV) negative patients. Normal liver and HCC genotypes were compared at 6 loci on 11p with 7 polymorphic probes detecting 10 restriction length polymorphisms (RFLPs). Each of the 8 paired normal-tumor tissue samples was informative for at least three different loci on 11p13-pter. None of them showed loss of constitutional heterozygosity for those markers. The retainment of 11p alleles suggests that mechanisms other than loss of tumor suppressor genes on llp are involved in hepatocarcinogenesis of HBV negative patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1980606     DOI: 10.1002/gcc.2870010409

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  3 in total

1.  Allelic imbalance on 16q in small, unifocal hepatocellular carcinoma: correlation with HBV and HCV infections and cellular proliferation rate.

Authors:  L Gramantieri; D Trerè; A Pession; F Piscaglia; L Masi; S Gaiani; A Mazziotti; L Bolondi
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

2.  Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.

Authors:  Susan C Abraham; Tsung-Teh Wu; Ralph H Hruban; Jae-Hyuk Lee; Charles J Yeo; Kevin Conlon; Murray Brennan; John L Cameron; David S Klimstra
Journal:  Am J Pathol       Date:  2002-03       Impact factor: 4.307

3.  Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.

Authors:  S F Ding; N A Habib; J Dooley; C Wood; L Bowles; J D Delhanty
Journal:  Br J Cancer       Date:  1991-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.